Mercer Global Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-102,425
Closed -$10.4M 3259
2025
Q4
$10.4M Buy
102,425
+4,429
+5% +$356K 0.02% 475
2025
Q3
$5.36M Buy
97,996
+39,170
+67% +$1.96M 0.01% 641
2025
Q2
$3.13M Buy
58,826
+16,469
+39% +$837K 0.01% 721
2025
Q1
$1.83M Buy
42,357
+2,869
+7% +$145K ﹤0.01% 862
2024
Q4
$2.22M Buy
39,488
+1,589
+4% +$98.9K 0.01% 790
2024
Q3
$2.58M Buy
37,899
+5,818
+18% +$328K 0.01% 690
2024
Q2
$1.36M Buy
32,081
+3,674
+13% +$202K ﹤0.01% 841
2024
Q1
$1.96M Buy
28,407
+2,409
+9% +$152K 0.01% 729
2023
Q4
$1.92M Sell
25,998
-8
-0% -$524 0.01% 754
2023
Q3
$1.77M Buy
26,006
+19,654
+309% +$1.67M 0.01% 748
2023
Q2
$596K Buy
+6,352
New +$496K ﹤0.01% 1151
2020
Q2
Sell
-3,676
Closed -$213K 1054
2020
Q1
$213K Sell
3,676
-102
-3% -$8.28K ﹤0.01% 919
2019
Q4
$349K Buy
+3,778
New +$332K 0.01% 863

Other funds holding EXAS

Mercer Global Advisors's EXAS Position: Q1 2026 in Review

Mercer Global Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 102,425 shares — an estimated $10.4M sold.

Mercer Global Advisors first reported a position in EXAS in Q4 2019 and held it in 13 quarters. The position peaked at $10.4M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Mercer Global Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Mercer Global Advisors sold 102,425 Exact Sciences shares in Q1 2026, an estimated $10.4M.
  • Mercer Global Advisors first reported a position in Exact Sciences in Q4 2019 and held it in 13 quarters.
  • Mercer Global Advisors's Exact Sciences position peaked at $10.4M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.